openPR Logo
Press release

Infantile Spasms Therapeutics Market Scope and Opportunities Analysis 2017 – 2025

03-21-2018 01:11 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Infantile Spasms Therapeutics Market Scope and Opportunities

Infantile spasms therapeutics are used for the treatment of seizures or an epilepsy syndrome in young children, usually aged one year or below. Infantile spasm refers to sudden stiffening of the body, the arms, and the legs or forward bending of the head. Primary treatments for infantile spams include steroid therapy and an anti-seizure medicine called Sabril. Infantile spasms are also known as the West syndrome, as the disease was first defined by Dr. William James West in the 1840s. These spasms generally begin in the first year of life, between three and eight months of age, and occur in two to three out of every 10,000 babies.

The disorder is more common in boys than girls. Family history is another cause– about 3% to 6% of cases can be linked to family history. The diagnosis of infantile spasms is carried out by physical and neurological examination, laboratory tests such as MRI of the brain, and blood and urine tests. Medication includes monotherapy as well as combination therapy. In approximately 20%–50% of the patients, infantile spasms evolve into the Lennox-Gastaut syndrome. Conversely, a similar percentage of patients with the Lennox-Gastaut syndrome have a history of infantile spasms.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35738

Growing number of births, rising prevalence of infantile spasms, product innovations, and technological advancements on the backdrop of extensive research and development activities are factors likely to drive the global infantile spasms therapeutics market. A recent advancement in this field is Seizure alert band, which notifies others when the patient is experiencing an epileptic seizure. This device aids in early diagnosis by doctors and increases life expectancy of the patient.

According to the National Organization for Rare Disorders, the incidence of infantile spasms is 2 to 3 per 10,000 live births, with a lifetime prevalence of 1.5 to 2 per 10,000 children. Increasing R&D investments, pipeline drugs, and government initiatives are a few more factors projected to propel the global infantile spasms therapeutics market in the near future. On the other hand, stringent regulations for product approval may hinder the market in the next few years.

Based on drug type, the infantile spasms therapeutics market has been segmented into monotherapy and combination therapy. The former has been sub-divided into adrenocorticotropic hormone, vigabatrin, and others (such as valproate, topiramate, zonisamide, clobazam, and clonazepam). In terms of distribution channel, the infantile spasms therapeutics market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=35738

Geographically, the infantile spasms therapeutics market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global infantile spasms therapeutics market and the trend is expected to continue during the forecast period.

The major share held by North America is attributable to early adoption of treatment procedures, innovation of new products, and large-scale R&D activities leading to technological advancements in the region. According to the Infantile Spasms Project, approximately 2000 to 4000 new cases of this disorder occur in the U.S. every year. Europe is the second leading market for infantile spasms therapeutics, due to the increasing research and development activities and rising geriatric population in the region.

The market in Asia Pacific is estimated to expand at a high rate during the forecast period, due to presence of a large target patient pool, rising disposable income of people, increasing government initiatives, growing R&D investments, and rising awareness about the disease among people in the region. Latin America and Middle East & Africa are projected to offer growth opportunities to the infantile spasms therapeutics market in the near future, due to the increasing investment by prominent global players, rising awareness about the disease, and rapid growth of the population in these regions.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=35738

Key players operating in the infantile spasms therapeutics market include H. Lundbeck A/S, Mallinckrodt Pharmaceuticals, Anavex Life Sciences Corp., Catalyst Pharmaceuticals, GW Pharmaceuticals plc, and Retrophin, Inc.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infantile Spasms Therapeutics Market Scope and Opportunities Analysis 2017 – 2025 here

News-ID: 987192 • Views:

More Releases from Transparency Market Research

mRNA Vaccine Market Comprehensive Analysis of Growth Trends and Future Opportunities - Expected to reach USD 9.6 billion by the year 2034
mRNA Vaccine Market Comprehensive Analysis of Growth Trends and Future Opportuni …
The mRNA vaccine market has witnessed significant attention and growth in recent years, primarily driven by the urgent need for vaccines to address global health challenges, notably the COVID-19 pandemic. Messenger RNA (mRNA) vaccines represent a revolutionary technology in immunology and vaccine development, offering high-speed production, adaptability, and effectiveness. These vaccines work by delivering genetic instructions to the body's cells, prompting an immune response that protects against diseases. In 2023, the
Companion Diagnostic Tests in Oncology Market Comprehensive Analysis of Growth Trends and Future Opportunities - Estimated to reach USD 17.0 billion by 2034
Companion Diagnostic Tests in Oncology Market Comprehensive Analysis of Growth T …
The companion diagnostic tests in oncology market is experiencing significant growth, driven by the increasing demand for personalized cancer treatments and the integration of targeted therapies. Companion diagnostic tests are crucial tools in oncology that help identify biomarkers indicating a patient's suitability for a specific therapy. This enables more precise treatment plans, better therapeutic outcomes, and minimized adverse effects. These tests are primarily categorized by detection techniques - protein detection,
Vitreous Tamponades Market Segmentation by Product Type Material End User and Application - Anticipated to achieve USD 117.8 million by 2034
Vitreous Tamponades Market Segmentation by Product Type Material End User and Ap …
The vitreous tamponades market is witnessing significant growth, driven by advancements in ophthalmic surgeries, a rising prevalence of retinal disorders, and an increasing number of surgical interventions worldwide. Vitreous tamponades are substances used in ophthalmology to support and stabilize the retina during vitreoretinal surgeries, specifically addressing conditions like retinal detachment, macular holes, and vitreous hemorrhage. These substances are categorized into two primary product types: Gaseous tamponades and Liquid tamponades, with
Global Bioclimatic Pergola Market to Reach $1 Billion by 2034, Driven by Sustainability and Innovation
Global Bioclimatic Pergola Market to Reach $1 Billion by 2034, Driven by Sustain …
The global bioclimatic pergola market is on the rise, fueled by increasing consumer demand for innovative, sustainable, and versatile outdoor living spaces. In 2023, the industry was valued at US$ 480.0 Mn, and it is projected to grow at an impressive CAGR of 7.1% from 2024 to 2034, reaching a valuation of US$ 1.0 Bn by the end of the forecast period. Bioclimatic pergolas, which combine functionality, sustainability, and aesthetic

All 5 Releases


More Releases for Infantile

Infantile Spasms Therapeutics Market Analysis by Key Players & Industry Size 202 …
According to a new report published by Allied Market Research, titled, " Infantile Spasms Therapeutics Market by Formulation Type (Solid and Liquid) and by Route of Administration (Oral and Parenteral) - Global Opportunity Analysis and Industry Forecast, 2021-2028" The Global market size of Immunomodulators is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from
Infantile Spasms Therapeutics Market to Boost Revenue with Massive Growth
Global Infantile Spasms Therapeutics Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Infantile Spasms Therapeutics Market by Formulation Type (Solid and Liquid)
Global Infantile Spasms Therapeutics Market 2018:- Mallinckrodt, H. Lundbeck, In …
Market Research Store Exposed a new deep Industry research report focuses on Infantile Spasms Therapeutics Market, delivers detailed analysis of market and future prospects of Infantile Spasms Therapeutics market. The critical and significant data in the study makes the research a very important tool for experts, analysts and managers to get ready-to-access analysis by the industry professionals. The Infantile Spasms Therapeutics Market report provides the complete analysis of Infantile Spasms
Infantile and Juvenile-onset Hypophosphatasia Treatment Market to Undertake Stra …
The Hypophosphatasia (HPP) is a rare genetic disease caused by mutations in the ALPL gene. It is a metabolic disorder that effects multiple body systems and leads to life-threatening complications. This disease leads to abnormal development of the bones due to defective bone mineralization and can lead to rickets, tempering of the bones that result in different types of bone abnormalities. The sign and symptoms include soft bones, hypercalcemia, short
Global Infantile Spasms Therapeutics Market 2017-2021
Qyresearchreports include new market research report Global Infantile Spasms Therapeutics Market Professional Survey Report 2017 to its huge collection of research reports. In a highly dynamic global market for Infantile Spasms Therapeutics, companies need to constantly evolve to stay ahead of the curve. To do so, they need accurate information on the market. The recent report endeavors to help them achieve their growth targets by offering crucial information on the global
Malignant Infantile Osteopetrosis Market to See Incredible Growth During 2027
Malignant Infantile osteopetrosis is also called as infantile autosomal recessive osteopetrosis. It is one of the rare skeletal dysplasia that is characterized using a radiographic pattern which shows increased bone density with involvement of the medullary portion. This type of disease typically manifests in infancy. Diagnosis of Malignant Infantile Osteopetrosis is based on radiographic evaluation and clinical evaluation, that is further confirmed using gene analysis technique if required. Due to